Drawing for KYSO KNOCK YOUR SOCKS OFF

USPTO serial 79368784

KYSO KNOCK YOUR SOCKS OFF

Reviewed by CopyMark Law Group

Reg. 7394274Status 700Registered
Filing date
Status date
Registration date
May 28, 2024
Examiner
GULIANO, ROBERT N
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KYSO KNOCK YOUR SOCKS OFF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; Biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disordersACTIVE—
005- Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disordersACTIVE—
042Medical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of theseACTIVE—
045Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 30, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 13, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 13, 2024FIMPFINAL DISPOSITION PROCESSED—
Aug 28, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 28, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 28, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 12, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2024GPNXNOTIFICATION PROCESSED BY IB—
Feb 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 24, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2023RFNTREFUSAL PROCESSED BY IB—
Oct 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 25, 2023RFRRREFUSAL PROCESSED BY MPU—
Oct 17, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 16, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2023DOCKASSIGNED TO EXAMINER—
Sep 15, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 9, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
May 5, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance